Anika Therapeutics, Inc.
ANIK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,329 | -$3,970 | -$4,873 | -$21,865 |
| Dep. & Amort. | $1,403 | $1,416 | $1,592 | $1,812 |
| Deferred Tax | $3 | -$3 | $18 | $234 |
| Stock-Based Comp. | $2,215 | $2,548 | $2,863 | $2,255 |
| Change in WC | $4,410 | -$3,833 | -$269 | -$2,363 |
| Other Non-Cash | $1,168 | $3,653 | $539 | $21,509 |
| Operating Cash Flow | $6,870 | -$189 | -$130 | $1,582 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,887 | -$1,467 | -$2,824 | -$1,307 |
| Net Acquisitions | $0 | $0 | $4,496 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $155 | $928 | $0 | $0 |
| Investing Cash Flow | -$1,732 | -$539 | $1,672 | -$1,307 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $261 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$3,971 | -$5,575 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$13 | -$82 | -$1,467 | $221 |
| Financing Cash Flow | -$13 | $179 | -$5,438 | -$5,354 |
| Forex Effect | -$302 | $345 | $108 | -$130 |
| Net Chg. in Cash | $4,823 | -$204 | -$3,788 | -$5,209 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53,167 | $53,371 | $57,159 | $62,368 |
| End Cash | $57,990 | $53,167 | $53,371 | $57,159 |
| Free Cash Flow | $4,983 | -$1,656 | -$2,954 | $275 |